Skip to main content
SpringerLink
Log in
Book cover

Experimental and Applied Immunotherapy

  • Book
  • © 2011

Overview

Editors:
  1. Jeffrey Medin

    1. University Health Network, University of Toronto, Toronto, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Daniel Fowler

    1. National Cancer Institute, Experimental Transplatation &, National Institutes of Health, Bethesda, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Reflects the inter-disciplinary nature of translational immunotherapy, and includes a description of the cellular players/molecular effectors and the distinct therapeutic strategies Ideal for laboratory researchers and post-baccalaureate level students Each chapter will present current clinical developments in the context of the biologic underpinnings that form the basis for the next-generation of immunotherapies.
  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages i-xvii
    Download chapter PDF

  2. T Cell Therapy: State-of-the-Art

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancer

      • Ulrike Gerdemann, Malcolm K. Brenner
      Pages 3-33

  3. Non-T Cell Therapeutic Approaches

    1. Front Matter

      Pages 35-35
      Download chapter PDF

    2. B Lymphocytes in Cancer Immunology

      • David Spaner, Angela Bahlo
      Pages 37-57

    3. Monoclonal Antibody Therapy for Cancer

      • Christoph Rader
      Pages 59-83

    4. Natural Killer Cells for Cancer Immunotherapy

      • Yoko Kosaka, Armand Keating
      Pages 85-105

    5. Dendritic Cell-Based Cancer Vaccines: Practical Considerations

      • Elizabeth Scheid, Michael Ricci, Ronan Foley
      Pages 107-126

    6. Mesenchymal Stromal Cells: An Emerging Cell-Based Pharmaceutical

      • Moïra François, Jacques Galipeau
      Pages 127-148

  4. T Cell Therapeutic Approaches

    1. Front Matter

      Pages 149-149
      Download chapter PDF

    2. Tumor-Specific Mutations as Targets for Cancer Immunotherapy

      • Brad H. Nelson, John R. Webb
      Pages 151-172

    3. Counteracting Subversion of MHC Class II Antigen Presentation by Tumors

      • Jacques Thibodeau, Marie-Claude Bourgeois-Daigneault, Réjean Lapointe
      Pages 173-194

    4. Mechanisms and Implications of Immunodominance in CD8+ T-Cell Responses

      • Claude Perreault
      Pages 195-206

    5. T Regulatory Cells and Cancer Immunotherapy

      • Adele Y. Wang, Megan K. Levings
      Pages 207-228

    6. Negative Regulators in Cancer Immunology and Immunotherapy

      • Wolfgang Zimmermann, Robert Kammerer
      Pages 229-249

    7. Genetically Engineered Antigen Specificity in T Cells for Adoptive Immunotherapy

      • Daniel J. Powell Jr, Bruce L. Levine
      Pages 251-278

  5. Non-Cellular Aspects of Cancer Immunotherapy

    1. Front Matter

      Pages 279-279
      Download chapter PDF

    2. Cytokine Immunotherapy

      • Megan Nelles, Vincenzo Salerno, Yixin Xu, Christopher J. Paige
      Pages 281-305

    3. Transcriptional Modulation Using Histone Deacetylase Inhibitors for Cancer Immunotherapy

      • Takashi Murakami
      Pages 307-322

    4. Combining Cancer Vaccines with Conventional Therapies

      • Natalie Grinshtein, Jonathan Bramson
      Pages 323-338
Back to top

Keywords

About this book

Immunotherapy is now recognized as an essential component of treatment for a wide variety of cancers. It is an interdisciplinary field that is critically dependent upon an improved understanding of a vast network of cross-regulatory cellular populations and a diversity of molecular effectors; it is a leading example of translational medicine with a favorable concept-to-clinical-trial timeframe of just a few years. There are many established immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use. Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmap leading to the creation of these future cancer-fighting immunotherapies. It includes essays by leading researchers that cover a wide variety of topics including T cell and non-T cell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymal stromal cells, negative regulators in cancer immunology and immunotherapy, non-cellular aspects of cancer immunotherapy, the combining of cancer vaccines with conventional therapies, the combining of oncolytic viruses with cancer immunotherapy, transplantation, and more. The field of immunotherapy holds great promise that will soon come to fruition if creative investigators can bridge seemingly disparate disciplines, such as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge.

Reviews

From the reviews:

“The text is divided into five parts, each comprising of one or more chapters written by word-renowned scientists in the field. … the editors have made an excellent effort to incorporate most relevant topics on immunotherapy in this textbook, and most chapters have been well written with supporting diagrams and tables. The text provides researchers in the field with up-to-date concepts and detailed current and future strategies for cancer immunotherapy.” (Ali Roghanian, Immunology News, May, 2012)

“Cancer immunotherapy is a vast area of research and it is covered in some depth by this very informative book. Each of the 19 chapters consists of a quick introduction to the specific area of interest of one of the contributors followed by in-depth analysis of experimental techniques currently being used successfully, or otherwise, in the field. … Overall, an enlightening book that covers a variety of immunotherapy techniques, but the book is directed specifically at those interested in cancer treatment.” (Donal Wall, Microbiology Today, November, 2011)

“A highly informative compendium of essays with a heavy focus on cancer immunotherapy. … the essays are excellent and present the state of the art of many emerging and established immunotherapies for cancer. … Immunisation approaches are considered by several authors. … I can recommend this excellent collection of succinct essays that span the breath of ongoing research in cancer immunotherapy.” (British Journal of Clinical Pharmacology, May, 2011)

Editors and Affiliations

  • University Health Network, University of Toronto, Toronto, Canada

    Jeffrey Medin

  • National Cancer Institute, Experimental Transplatation &, National Institutes of Health, Bethesda, USA

    Daniel Fowler

Bibliographic Information

  • Book Title: Experimental and Applied Immunotherapy

  • Editors: Jeffrey Medin, Daniel Fowler

  • DOI: https://doi.org/10.1007/978-1-60761-980-2

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2011

  • Hardcover ISBN: 978-1-60761-979-6Published: 06 December 2010

  • Softcover ISBN: 978-1-62703-822-5Published: 26 September 2014

  • eBook ISBN: 978-1-60761-980-2Published: 03 December 2010

  • Edition Number: 1

  • Number of Pages: XVII, 442

  • Topics: Immunology, Cell Biology

Publish with us

Policies and ethics

Back to top

Search

Navigation